Nasdaq warns Sadot Group (NASDAQ: SDOT) after 30 days under $1 bid
Rhea-AI Filing Summary
Sadot Group Inc. received a Nasdaq notice that its common stock no longer meets the $1.00 minimum bid price requirement after closing below that level for 30 consecutive business days from July 28, 2025 through September 8, 2025.
The company is not eligible for the standard 180‑day grace period because it completed a 1‑for‑10 reverse stock split on October 18, 2024 within the prior year. Nasdaq staff has determined that the stock will be delisted from The Nasdaq Capital Market unless Sadot Group requests a hearing, and the company intends to timely seek a hearing, which will automatically stay any suspension or delisting action during the hearing process and any extension granted.
Positive
- None.
Negative
- Nasdaq delisting risk: Nasdaq has issued a determination to delist Sadot Group’s common stock after it traded below the $1.00 minimum bid price for 30 consecutive business days, and the company is ineligible for the standard 180‑day compliance period due to a recent 1‑for‑10 reverse stock split.
Insights
Nasdaq has started a delisting process for Sadot Group after a prolonged sub‑$1 share price, though a hearing will delay any immediate removal.
Sadot Group Inc. has fallen out of compliance with Nasdaq Listing Rule 5550(a)(2), which requires a minimum bid price of $1.00 per share. The stock closed below this threshold for 30 consecutive business days from July 28, 2025 through September 8, 2025, prompting Nasdaq staff to issue a determination to delist the shares from The Nasdaq Capital Market.
The company is not eligible for the usual 180‑day cure period because it executed a 1‑for‑10 reverse stock split on October 18, 2024, within the prior one‑year window. That prior reverse split limits standard relief options and moves the situation directly into a formal hearings process rather than an automatic grace period.
Sadot Group intends to request a hearing before a Nasdaq Hearings Panel under the Nasdaq Listing Rule 5800 Series. This request will automatically stay any suspension or delisting action while the hearing is pending and for any additional extension period granted by the panel, so near‑term trading will continue on Nasdaq, but the longer‑term listing outcome will depend on the panel’s decision and any remedial steps the company presents.